{
  "id": "R43038",
  "type": "CRS Report",
  "typeId": "REPORT",
  "number": "R43038",
  "active": false,
  "source": "University of North Texas Libraries Government Documents Department",
  "versions": [
    {
      "source": "University of North Texas Libraries Government Documents Department",
      "sourceLink": "https://digital.library.unt.edu/ark:/67531/metadc462058/",
      "id": "R43038_2013Apr12",
      "date": "2013-04-12",
      "retrieved": "2014-12-05T09:57:41",
      "title": "Federal Authority to Regulate the Compounding of Human Drugs",
      "summary": "This report will examine the FDA's regulation of drug compounding and will discuss relevant legal authorities. The report will conclude by discussing potential limits to the FDA's authority to regulate human drug compounding.",
      "type": "CRS Report",
      "typeId": "REPORT",
      "active": false,
      "formats": [
        {
          "format": "PDF",
          "filename": "files/20130412_R43038_269d3245e2791973d60a661ab979811284ecef9b.pdf"
        },
        {
          "format": "HTML",
          "filename": "files/20130412_R43038_269d3245e2791973d60a661ab979811284ecef9b.html"
        }
      ],
      "topics": [
        {
          "source": "LIV",
          "id": "Medicine",
          "name": "Medicine"
        },
        {
          "source": "LIV",
          "id": "Health care industry",
          "name": "Health care industry"
        },
        {
          "source": "LIV",
          "id": "Pharmacies",
          "name": "Pharmacies"
        },
        {
          "source": "LIV",
          "id": "Drug law and legislation",
          "name": "Drug law and legislation"
        },
        {
          "source": "LIV",
          "id": "Consumer protection",
          "name": "Consumer protection"
        }
      ]
    }
  ],
  "topics": []
}